Clinical Trials Directory

Trials / Completed

CompletedNCT03477682

Postoperative Management of Groin Flaps for Vascular Coverage

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a randomized controlled trial designed to analyze the impact of bedrest duration on return to functional independence at discharge following sartorius flap for coverage of vascular reconstruction in the groin.

Detailed description

This is a pilot prospective study with the purpose of evaluating the impact of bedrest duration on outcomes of groin muscle flaps used for groin coverage in patients undergoing open, infrainguinal vascular surgery. The investigators plan to target all patients undergoing groin muscle flaps for vascular groin coverage at UCSF. All patients undergoing groin flaps will be block randomized into two cohorts: Cohort 1 - one day of bedrest (mobilize on post-op day 2) versus Cohort 2 - 5 days of bedrest (mobilize on post-op day 6). The investigators perform approximately 50 infrainguinal muscle flaps per year. They aim to enroll 30 patients (15 per cohort). Outcome measures include: surgical complication rates (including wound and lymphatic complications, readmissions, and reoperations), physical function, hospital length of stay, venous thromboembolism (VTE), and rates of discharge to a skilled nursing facility. The investigators will also examine the impact of bedrest on patient reported outcomes one month following surgery. Patient outcomes will be followed for 3 months post-operatively.

Conditions

Interventions

TypeNameDescription
OTHEREarly ambulationPatients who are in the experimental arm will have a shorter duration of bedrest restriction following sartorius surgery (1 day) versus the standard group (5 days bedrest).

Timeline

Start date
2017-11-07
Primary completion
2020-03-25
Completion
2021-06-30
First posted
2018-03-26
Last updated
2021-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03477682. Inclusion in this directory is not an endorsement.